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1. Introduction
Systemic lupus erythematosus is the prototype of autoimmune disorder, which 
is typically manifesting in multiple organ systems and running a chronic course, 
affecting primarily females. It is associated with significant public health impact 
in affected individuals, with highly heterogenous presentation and progression. 
During the last two decades, substantial progress has been made in our knowledge 
on systemic lupus erythematosus incidence, pathogenesis, therapeutic interven-
tions, and long-term outcomes. However, it remains a challenging area of research, 
especially considering the genetic, epigenetic, and environmental factors that 
have been found to play a crucial role in disease prognosis [1]. Estimates on the 
worldwide incidence and prevalence of lupus revealed that the highest incidence 
was found in North America, while the lowest rates have been reported in Northern 
Australia [2]. Interestingly, a registry from the island of Crete reported that the 
overall age-adjusted/sex-adjusted incidence is growing among males [3]. Factors 
such as age, gender, ethnicity, genetics, hormonal status and environmental factors 
appear to have a central function in the development of the disease [2].
2. The new era of systemic lupus erythematosus
Despite the significant improvements which have been achieved in the field of 
lupus, including the overall management and immunosuppressive agents used for 
therapy, mortality rates of affected patients remain three times higher than those in 
the general population [2]. In particular, patients with lupus nephritis, who end up 
in end-stage kidney disease, inquire a huge burden of morbidity, related not only 
to the dialysis procedure but also to the inflammatory background, the impact of 
cumulative immunosuppression, and the phenomenon of accelerated atherosclero-
sis which results in cardiovascular death [4]. Still the performance of each patient is 
variable. For instance, neurologic and psychiatric manifestations of systemic lupus 
erythematosus appear to have an increasing rate in recent reports although they are 
found in different frequencies across lupus cohorts, depending on the methodology 
used to define the related signs/symptoms and the screening practice [5]. Likewise, 
family planning becomes a crucial problem for women with systemic lupus ery-
thematosus, considering the fact that females of reproductive age are the most 
frequently affected patients. Pregnancies in patients with active lupus and especially 
in those with renal involvement have been associated with significant morbidity and 
mortality for both the mother and the fetus [6]. Moreover, the interplay between 
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environmental factors and the genetic profile of each individual appear to be of 
great importance with respect to the onset and the progression of this disorder [7, 8]. 
Given these circumstances, we consider systemic lupus erythematosus a challenging 
field of research, which enquires continuing updating in order to illustrate all cur-
rent knowledge regarding disease pathogenesis and provide guidelines for clinical 
practice employing all newer immunosuppressive agents.
Author details
Sophia Lionaki and Ioannis Boletis
Department of Nephrology and Transplantation, Faculty of Medicine, Laiko 
Hospital, National and Kapodistrian University of Athens, Athens, Greece
*Address all correspondence to: sofia.lionaki@gmail.com
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
3Introductory Chapter: Recent Advances in Systemic Lupus Erythematosus
DOI: http://dx.doi.org/10.5772/intechopen.88226
References
[1] Parks CG, de Souza Espindola 
Santos A, Barbhaiya M, 
Costenbader KH. Understanding the 
role of environmental factors in 
the development of systemic lupus 
erythematosus. Best Practice & 
Research. Clinical Rheumatology. 
2017;31(3):306-320
[2] Stojan G, Petri M. Epidemiology 
of systemic lupus erythematosus: 
An update. Current Opinion in 
Rheumatology. 2018;30(2):144-150
[3] Gergianaki I, Bortoluzzi A, 
Bertsias G. Update on the epidemiology, 
risk factors, and disease outcomes 
of systemic lupus erythematosus. 
Best Practice & Research. Clinical 
Rheumatology. 2018;32(2):188-205
[4] Mageau A, Timsit JF, Perrozziello A, 
Ruckly S, Dupuis C, Bouadma L, 
et al. The burden of chronic kidney 
disease in systemic lupus 
erythematosus: A nationwide 
epidemiologic study. Autoimmunity 
Reviews. Jul 2019;18(7):733-737. pii: 
S1568-9972(19)30114-4
[5] Tani C, Palagini L, 
Moraes-Fontes MF, Carli L, Mauri M, 
Bombardieri S, et al. Neuropsychiatric 
questionnaires in systemic lupus 
erythematosus. Clinical and 
Experimental Rheumatology. 2014;32 
(5 Suppl 85):S-59-S-64
[6] Nahal SK, Selmi C,  
Gershwin ME. Safety issues and 
recommendations for successful 
pregnancy outcome in systemic 
lupus erythematosus. Journal of 
Autoimmunity. 2018;93:16-23
[7] Javinani A, Ashraf-Ganjouei A, Aslani S, 
Jamshidi A, Mahmoudi M. Exploring 
the etiopathogenesis of systemic lupus 
erythematosus: A genetic perspective. 
Immunogenetics. 2019;71(4):283-297
[8] Patrias K. Citing Medicine: The NLM 
Style Guide for Authors, Editors, and 
Publishers [Internet]. Bethesda, MD: 
National Library of Medicine (US); 
2007. [Updated: 2 October 2015; Cited: 
13 October 2016]. Available from: 
http://www.nlm.nih.gov/citingmedicine
